Citations

Clear

1011 citation(s) found for "Barry, WT".

Elevation of cAMP in Mesenchymal Stem Cells Transiently Upregulates Neural Markers Rather than Inducing Neural Differentiation
Rooney, Gemma E., Howard, Linda , O’Brien, Timothy , Windebank, Anthony J. , Barry, Frank

Mayo Clinic

Stem Cells and Development | June 13, 2008 | Volume: 18 | Issue: 3 | Pages: 387-398

10.1089/scd.2008.0080 | PMID 18554089 Get It

The aims of this research were to examine the neural expression profile of undifferentiated mesenchymal stem cells (MSCs), to define a serum-free environment that would support the survival of MSCs, and to assess the effects of elevated cyclic adenosine monophosphate (cAMP) levels on MSC morphology and expression of neural markers. The neural profile of MSCs was assessed using immunocytochemistry and real-time polymerase chain reaction (PCR) techniques. These MSCs were then cultured in varying serum-free environments, with flow cytometry analysis of cell viability and apoptosis. The effects of forskolin and 8 bromo-cAMP treatment on MSC morphology and expression of neural markers were assessed using light microscopy, immunocytochemistry and real-time PCR analysis. Expression of the neural markers nestin, vimentin, β III tubulin, glial fibrillary acidic protein, and the tropomyosin-related kinases was demonstrated in normal undifferentiated MSCs. Furthermore, MSCs cultured in serum-free conditions containing ascorbic acid 2-phosphate demonstrated greater long-term survival and reduced apoptosis. In contrast, forskolin increased the percentage of cells undergoing apoptosis. Culture in the presence of forskolin induced a 6-fold increase in β III tubulin expression after a 6-h exposure time, which was accompanied by dramatic changes in morphology. However, this effect was transient, with the cells reverting to their normal morphology by 24 h. Treatment with 8 bromo-cAMP induced similar increases in β III tubulin expression without such dramatic morphological changes. Factors which increase the concentration of cAMP induce transient changes in expression of neural markers that appear to be the result of cellular adaptation to changes in culture conditions rather than a real process of neural differentiation.
Gene-Modified Mesenchymal Stem Cells Express Functionally Active Nerve Growth Factor on an Engineered Poly Lactic Glycolic Acid (PLGA) Substrate
Rooney, Gemma E., Moran, Cathal J., McMahon, Siobhán S. , Ritter, Thomas , Maenz, Martin, Flügel, Alexander , Dockery, Peter , O’Brien, Timothy , Howard, Linda , Windebank, Anthony J. , Barry, Frank

Mayo Clinic

Tissue Engineering Part A | April 11, 2008 | Volume: 14 | Issue: 5 | Pages: 681-690

10.1089/tea.2007.0260 | PMID 18402551 Get It

Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo
Kalyuzhniy, Oleksandr , Paolo, Nelson C. Di, Silvestry, Mariena, Hofherr, Sean, Barry, Michael A. , Stewart, Phoebe L. , Shayakhmetov, Dmitry M. , Barry, Michael A

Mayo Clinic

Proceedings of the National Academy of Sciences | April 7, 2008 | Volume: 105 | Issue: 14 | Pages: 5483-5488

10.1073/pnas.0711757105 | PMID 18391209 Get It

Human species C adenovirus serotype 5 (Ad5) is the most common viral vector used in clinical studies worldwide. Ad5 vectors infect liver cells in vivo with high efficiency via a poorly defined mechanism, which involves virus binding to vitamin K-dependent blood coagulation factors. Here, we report that the major Ad5 capsid protein, hexon, binds human coagulation factor X (FX) with an affinity of 229 pM. This affinity is 40-fold stronger than the reported affinity of Ad5 fiber for the cellular receptor coxsackievirus and adenovirus receptor, CAR. Cryoelectron microscopy and single-particle image reconstruction revealed that the FX attachment site is localized to the central depression at the top of the hexon trimer. Hexon-mutated virus bearing a large insertion in hexon showed markedly reduced FX binding in vitro and failed to deliver a transgene to hepatocytes in vivo . This study describes the mechanism of FX binding to Ad5 and demonstrates the critical role of hexon for virus infection of hepatocytes in vivo .
Synthesis and Conformational Evaluation of a Novel Gene Delivery Vector for Human Mesenchymal Stem Cells
Saraf, Anita , Hacker, Michael C. , Sitharaman, Balaji , Grande‐Allen, K. Jane , Barry, Michael A. , Mikos, Antonios G. , Barry, Michael A

Mayo Clinic

Biomacromolecules | February 5, 2008 | Volume: 9 | Issue: 3 | Pages: 818-827

10.1021/bm701146f | PMID 18247565 Get It

Response to Letter Regarding Article, “Cardiac Structure and Ventricular–Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota”
Roger, Véronique L. , Rodeheffer, Richard J. , Ommen, Steve R. , Redfield, Margaret M. , Bursi, Francesca , Lam, Carolyn S.P. , Borlaug, Barry A. , Kass, David A. , Bursi, Francesca

Mayo Clinic

Circulation | December 10, 2007 | Volume: 116 | Issue: 24 | Pages: No page available

10.1161/circulationaha.107.736504 Get It

T-Cell Receptors and Collagen Induced Arthritis in H-2 R Mice
Cole, Barry C., Ito, Jun , Harper, D.S., Anderson, Gary D., Luthra, Harvinder S., David, Chella S., Griffiths, Marie , Cannon, Grant W.

Mayo Clinic

Autoimmunity | November 22, 2007 | Volume: 14 | Issue: 3 | Pages: 221-229

10.3109/08916939309077369 | PMID 8329559 Get It

Molecular and Functional Characterization of Novel Glycerol-3-Phosphate Dehydrogenase 1–Like Gene ( GPD1-L ) Mutations in Sudden Infant Death Syndrome
Norstrand, David W. Van, Valdivia, Carmen R. , Tester, David J. , Ueda, Kazuo , London, Barry , Makielski, Jonathan C., Ackerman, Michael J. , London, Barry

Mayo Clinic

Circulation | October 29, 2007 | Volume: 116 | Issue: 20 | Pages: 2253-2259

10.1161/circulationaha.107.704627 | PMID 17967976 Get It

Background— Autopsy-negative sudden unexplained death, including sudden infant death syndrome, can be caused by cardiac channelopathies such as Brugada syndrome (BrS). Type 1 BrS, caused by mutations in the SCN5A -encoded sodium channel, accounts for ≈20% of BrS. Recently, a novel mutation in the glycerol-3-phosphate dehydrogenase 1–like gene ( GPD1-L ) disrupted trafficking of SCN5A in a multigenerational family with BrS. We hypothesized that mutations in GPD1-L may be responsible for some cases of sudden unexplained death/sudden infant death syndrome. Methods and Results— Using denaturing high-performance liquid chromatography and direct DNA sequencing, we performed comprehensive open-reading frame/splice site mutational analysis of GPD1-L on genomic DNA extracted from necropsy tissue of 83 unrelated cases of sudden unexplained death (26 females, 57 males; average age, 14.6±10.7 years; range, 1 month to 48 years). A putative, sudden unexplained death–associated GPD1-L missense mutation, E83K, was discovered in a 3-month-old white boy. Further mutational analysis was then performed on genomic DNA derived from a population-based cohort of 221 anonymous cases of sudden infant death syndrome (84 females, 137 males; average age, 3±2 months; range, 3 days to 12 months), revealing 2 additional mutations, I124V and R273C, in a 5-week-old white girl and a 1-month-old white boy, respectively. All mutations occurred in highly conserved residues and were absent in 600 reference alleles. Compared with wild-type GPD1-L, GPD1-L mutations coexpressed with SCN5A in heterologous HEK cells produced a significantly reduced sodium current ( P <0.01). Adenovirus-mediated gene transfer of the E83K–GPD1-L mutation into neonatal mouse myocytes markedly attenuated the sodium current ( P <0.01). These decreases in current density are consistent with sodium channel loss-of-function diseases like BrS. Conclusions— The present study is the first to report mutations in GPD1-L as a pathogenic cause for a small subset of sudden infant death syndrome via a secondary loss-of-function mechanism whereby perturbations in GPD1-L precipitate a marked decrease in the peak sodium current and a potentially lethal BrS-like proarrhythmic substrate.
Mutation in Glycerol-3-Phosphate Dehydrogenase 1–Like Gene ( GPD1-L ) Decreases Cardiac Na + Current and Causes Inherited Arrhythmias
London, Barry , Michalec, Michael, Mehdi, Haider , Zhu, Xiaodong , Kerchner, Laurie J. , Sanyal, Shamarendra, Viswanathan, Prakash C., Pfahnl, Arnold , Shang, Lijuan L., Madhusudanan, Mohan, Baty, Catherine J. , Lagana, Stephen M. , Gutmann, Rebecca, Ackerman, Michael J. , McNamara, Dennis M. , Dudley, Samuel C. , Aleong, Ryan G. , Weiss, Raul , London, Barry

Mayo Clinic

Circulation | October 29, 2007 | Volume: 116 | Issue: 20 | Pages: 2260-2268

10.1161/circulationaha.107.703330 | PMID 17967977 Get It

Background— Brugada syndrome is a rare, autosomal-dominant, male-predominant form of idiopathic ventricular fibrillation characterized by a right bundle-branch block and ST elevation in the right precordial leads of the surface ECG. Mutations in the cardiac Na + channel SCN5A on chromosome 3p21 cause ≈20% of the cases of Brugada syndrome; most mutations decrease inward Na + current, some by preventing trafficking of the channels to the surface membrane. We previously used positional cloning to identify a new locus on chromosome 3p24 in a large family with Brugada syndrome and excluded SCN5A as a candidate gene. Methods and Results— We used direct sequencing to identify a mutation (A280V) in a conserved amino acid of the glycerol-3-phosphate dehydrogenase 1–like ( GPD1-L ) gene. The mutation was present in all affected individuals and absent in >500 control subjects. GPD1-L RNA and protein are abundant in the heart. Compared with wild-type GPD1-L, coexpression of A280V GPD1-L with SCN5A in HEK cells reduced inward Na + currents by ≈50% ( P <0.005). Wild-type GPD1-L localized near the cell surface to a greater extent than A280V GPD1-L. Coexpression of A280V GPD1-L with SCN5A reduced SCN5A cell surface expression by 31±5% ( P =0.01). Conclusions— GPD1-L is a novel gene that may affect trafficking of the cardiac Na + channel to the cell surface. A GPD1-L mutation decreases SCN5A surface membrane expression, reduces inward Na + current, and causes Brugada syndrome.
Polyethylene Glycol Modification of Adenovirus Reduces Platelet Activation, Endothelial Cell Activation, and Thrombocytopenia
Hofherr, Sean, Mok, Hoyin, Gushiken, Francisca C., López, José A. , Barry, Michael A. , Barry, Michael A

Mayo Clinic

Human Gene Therapy | September 3, 2007 | Volume: 18 | Issue: 9 | Pages: 837-848

10.1089/hum.2007.0051 | PMID 17767399 Get It

Cardiac Structure and Ventricular–Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota
Roger, Véronique L. , Rodeheffer, Richard J. , Bursi, Francesca , Ommen, Steve R. , Redfield, Margaret M. , Lam, Carolyn S.P. , Borlaug, Barry A. , Kass, David A. , Bursi, Francesca

Mayo Clinic

Circulation | April 3, 2007 | Volume: 115 | Issue: 15 | Pages: 1982-1990

10.1161/circulationaha.106.659763 | PMID 17404159 Get It

Background— Mechanisms purported to contribute to the pathophysiology of heart failure with normal ejection fraction (HFnlEF) include diastolic dysfunction, vascular and left ventricular systolic stiffening, and volume expansion. We characterized left ventricular volume, effective arterial elastance, left ventricular end-systolic elastance, and left ventricular diastolic elastance and relaxation noninvasively in consecutive HFnlEF patients and appropriate controls in the community. Methods and Results— Olmsted County (Minn) residents without cardiovascular disease (n=617), with hypertension but no heart failure (n=719), or with HFnlEF (n=244) were prospectively enrolled. End-diastolic volume index was determined by echo Doppler. End-systolic elastance was determined using blood pressure, stroke volume, ejection fraction, timing intervals, and estimated normalized ventricular elastance at end diastole. Tissue Doppler e′ velocity was used to estimate the time constant of relaxation. End-diastolic volume (EDV) and Doppler-derived end-diastolic pressure (EDP) were used to derive the diastolic curve fitting (α) and stiffness (β) constants (EDP=αEDV β ). Comparisons were adjusted for age, sex, and body size. HFnlEF patients had more severe renal dysfunction, yet smaller end-diastolic volume index and cardiac output and increased EDP compared with both hypertensive and healthy controls. Arterial elastance and ventricular end-systolic elastance were similarly increased in hypertensive controls and HFnlEF patients compared with healthy controls. In contrast, HFnlEF patients had more impaired relaxation and increased diastolic stiffness compared with either control group. Conclusions— From these cross-sectional observations, we speculate that the progression of diastolic dysfunction plays a key role in the development of heart failure symptoms in persons with hypertensive heart disease.